⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
AKBA News
Akebia Therapeutics, Inc.
Akebia Therapeutics to Conduct Investor Meetings at the Raymond James 2026 Biotech Innovation Symposium
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Form 8-K
sec.gov
AKBA
Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers, Ph.D. to its Board of Directors
globenewswire.com
AKBA
Braveheart Bio Appoints Emil deGoma, M.D., as Chief Medical Officer
prnewswire.com
AKBA
Akebia Therapeutics to Host Virtual R&D Day Highlighting Robust Kidney Disease Pipeline, on April 2, 2026
globenewswire.com
AKBA
Breath Analyzers Market worth $5.63 billion by 2031 | MarketsandMarkets™
prnewswire.com
LOCO
ABT
AKBA
BAC
CMII
Akebia Therapeutics to Present at the Leerink Partners 2026 Global Healthcare Conference
globenewswire.com
AKBA
Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
AKBA
Form 8-K
sec.gov
AKBA